Fluorescent antibody studies of human breast cancer12

Eugene M. Edynak, Yashar Hirshaut, Michael Bernhar, Germain Trempe

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Indirect immunofluorescence studies with sera from breast cancer patients were conducted on cell lines derived from human breast cancers. A new antigen was demonstrated in 2 primary cell cultures of 11 primary and established lines of breast carcinoma studied. Eighty-five percent of cells per field demonstrated an intense granular cytoplasmic fluorescence. Thirty-five additional cell lines of primary and established cultures derived from normal cells and from tumors of nonbreast origin including 7 human sarcoma cultures were negative where tested with positive sera. Ninety-one percent (22/24) of sera of breast cancer patients free of metastatic disease obtained 7-10 days after surgery were positive for antibody, whereas only 20% (4/20) of sera of age- and parity-adjusted normal donors were positive. Absorption studies with extracts of cell cultures of sarcomas and of a cell culture AlAb of breast origin (antigen negative) did not remove fluorescent antibody activity. A titer as high as 1: 160 was found in the serum of one breast cancer patient. The antibody class was identified as predominantly IgG.—J Nat Cancer Inst

Original languageEnglish
Pages (from-to)1137-1143
Number of pages7
JournalJournal of the National Cancer Institute
Volume48
Issue number4
DOIs
StatePublished - Apr 1972
Externally publishedYes

Fingerprint

Dive into the research topics of 'Fluorescent antibody studies of human breast cancer12'. Together they form a unique fingerprint.

Cite this